Melanoma trials in Norway

In Norway 9 Also abroad 578

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Where
Bergen, Oslo
Age
18 years and over
People
254 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07492680
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Lørenskog, Oslo
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 2Taking people
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
Where
Oslo
Age
18 years to 120 years
People
218 worldwide
Run by
Melanoma Institute Australia
See details and how to joinNCT03340129 · EU 2024-518545-13-00
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Bodo, Drammen, Oslo
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 3Taking people
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Where
Oslo
Age
18 years and over
People
290 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00
Phase 3Taking people
A Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared to Ipilimumab and Nivolumab Only in Patients with Uveal Melanoma Liver Metastases – the SCANDIUM III trial.
Where
Oslo
Age
18 years and over
People
50 worldwide
Run by
Vaestra Goetalandsregionen
See details and how to join2023-508156-20-00 · EU 2023-508156-20-00
Phase 3Taking people
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Where
Aalesund, Bergen, Drammen, Kristiansand S, Lorenskog, Oslo, Stavanger, Toensberg, Tromsoe, Trondheim
Age
18 years and over
People
1,792 worldwide
Run by
Uppsala University
See details and how to joinNCT06488482 · EU 2023-509994-22-00
Phase 3Taking people
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Where
Bergen, Oslo
Age
18 years and over
People
680 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT06112314
Phase 2Taking people
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
Where
Bergen, Oslo
Age
18 years and over
People
27
Run by
Oslo University Hospital
See details and how to joinNCT06651151 · EU 2023-508649-42-00